Bruce Cozadd plans 6,000-share Jazz Pharmaceuticals (JAZZ) stock sale after prior sales

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc reporting person Bruce Cozadd plans to sell 6,000 shares of common stock through Merrill Lynch on or after August 3, 2026 on NASDAQ. The shares relate to stock options dated February 28, 2019.

Cozadd also reports sales of 6,000 common shares in each of the prior three months: on May 1, 2026 for $1,213,980, on June 1, 2026 for $1,410,720, and on July 1, 2026 for $1,442,820.

Key Figures

Planned shares to be sold: 6,000 shares Past sale on May 1, 2026: $1,213,980 Past sale on June 1, 2026: $1,410,720 +2 more

5 metrics

Planned shares to be sold 6,000 shares Common stock sale planned on or after August 3, 2026

Past sale on May 1, 2026 $1,213,980 Proceeds reported for 6,000-share sale of common stock

Past sale on June 1, 2026 $1,410,720 Proceeds reported for 6,000-share sale of common stock

Past sale on July 1, 2026 $1,442,820 Proceeds reported for 6,000-share sale of common stock

Option grant date 02/28/2019 Stock option associated with planned 6,000-share sale

Key Terms

Form 144, Stock Option, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Form 144 regulatory

"according to a Form 144 notice of proposed sale"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option financial

"02/28/2019 | Stock Option | Jazz Pharmaceuticals PLC"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:17 PM Accepted by SEC EDGAR 08/03/2026 - 04:16 PM Learn about SEC filing dates

FAQ

What stock sale is Bruce Cozadd planning for Jazz (JAZZ)?

Bruce Cozadd plans to sell 6,000 shares of Jazz Pharmaceuticals common stock through Merrill Lynch on or after August 3, 2026 on NASDAQ, according to a Form 144 notice of proposed sale.

How many Jazz (JAZZ) shares has Bruce Cozadd sold in the past three months?

Bruce Cozadd reports selling 6,000 shares of Jazz Pharmaceuticals common stock in each of the last three months, on May 1, June 1, and July 1, 2026, for separate dollar amounts each month.

What dollar amounts were received in Bruce Cozadd’s recent Jazz (JAZZ) stock sales?

Reported sales were for $1,213,980 on May 1, 2026, $1,410,720 on June 1, 2026, and $1,442,820 on July 1, 2026, each tied to a 6,000-share sale of Jazz Pharmaceuticals common stock.

Which broker and market are used for Bruce Cozadd’s planned Jazz (JAZZ) sale?

The planned 6,000-share sale of Jazz Pharmaceuticals common stock is to be executed through Merrill Lynch on the NASDAQ market, as specified in the Form 144 notice of proposed sale.

What is the origin of the Jazz (JAZZ) shares Bruce Cozadd plans to sell?

The 6,000 Jazz Pharmaceuticals common shares planned for sale are associated with a stock option dated February 28, 2019, indicating the shares arise from option-related equity compensation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 3075A Hansen Way 1st Floor Palo Alto CA 94304	6000	1517880	62742820	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2019	Stock Option	Jazz Pharmaceuticals PLC			6000	02/28/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	07/01/2026	6000	1442820
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	06/01/2026	6000	1410720
Bruce Cozadd 5th Floor Waterloo Exchange Waterloo Road Dublin L2 D04-E5W7	Common	05/01/2026	6000	1213980

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)